Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases

British Journal of Cancer

Volumn 99, Issue 5, 2008, Pages 741-749

  Kim, S H ^a   Castro, F ^a   Gonzalez, D ^a   Maciag, P C ^b,c   Paterson, Y ^c   Gravekamp, C ^a,d  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b ADVAXIS INC   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

4T1 model; Breast cancer metastases; Listeria monocytogenes; Mage b DNA vaccine

Indexed keywords

CANCER VACCINE; COMPLEMENTARY DNA; HYBRID PROTEIN; LISTERIOLYSIN O; MELANOMA ANTIGEN; MELANOMA ANTIGEN B; PLASMID DNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CD8+ T LYMPHOCYTE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; LISTERIA MONOCYTOGENES; LYMPH NODE; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SPLEEN; TUMOR MODEL; VACCINATION;

ANIMALS; ANTIGENS, NEOPLASM; BASE SEQUENCE; CANCER VACCINES; CELL LINE, TUMOR; DNA PRIMERS; FEMALE; LISTERIA MONOCYTOGENES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NEOPLASM PROTEINS; RECOMBINATION, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 50249100180     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604526     Document Type: Article

References (46)

1. Alberg AJ, Singh S (2001) Epidemiology of breast cancer in older women: implications for future health care. Drugs Aging 18: 761-762
2. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA (2005) Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 34: 405-412
3. Aslakson CJ, Miller FR (1992) Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 152: 1399
4. Berkowitz N, Gupta S, Silberman G (2000) Estimates of the lifetime direct costs of treatment for metastatic breast cancer. Value Health 3: 23-30
5. Celis JE, Moreira JMA, Cabezon T, Gromov P, Friis E, Rank F, Gromova I (2005) Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients. Mol Cell Proteomics 4: 492-522
6. Chambers RS, Johnston SA (2003) High-level generation of polyclonal antibodies by genetic immunization. Nature Biotechnol 21: 1088-1092
7. Chaput N, Darasse-Jeze G, Bergot AS, Cordier C, Ngo-Abdalla S, Klatzmann D, Azogui O (2007) Regulatory T cells prevent CD8 T cell maturation by inhibiting CD4 Th cells at tumor sites. J Immunol 179: 4969-4978
8. Chikamatsu K, Sakakura K, Yamamoto T, Furaya N, Whiteside TL, Masuyama K (2008) CD4+ T helper responses insquamous cell carcinoma of the head and neck. Oral Oncol DOI:10.1016/j.oraloncology.2007.11.001
9. Conze D, Weiss L, Regen PS, Bhushan A, Weaver D, Johnson P, Rincón M (2001) Autocrine production of interleukin-6 causes multidrug resistance in breast cancer cells. Cancer Res 61: 8851-8858
10. De Backer O, Verheyden AM, Martin B, Godelaine D, De Plaen E, Brasseur R, Avner P, Boon T (1995) Structure, chromosomal location, and expression pattern of three mouse genes homologous to the human MAGE genes. Genomics 28: 74-83
11. De Plaen E, De Backer O, Arnaud D, Bonjean B, Chomez P, Martelange V, Avner P, Baldacci P, Babinet C, Hwang SY, Knowles B, Boon T (1999) A new family of mouse genes homologous to the human MAGE genes. Genomics 55: 176-184
12. DiPaolo RJ, Brinster C, Davidson TS, Andersson J, Glass D, Shevach EM (2007) Autoantigen-specific TGFβ-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J Immunol 179: 4685-4693
13. Gajewski TF, Meng Y, Harlin H (2006) Immune suppression in tumor microenvironment. J Immunother 29: 233-240
14. Gravekamp C (2007) Cancer vaccines in old age. Exp Ger 42: 441-450
15. Gravekamp C, Leal B, Denny A, Bahar R, Lampkin S, Castro F, Kim SH, Moore D, Reddick R (2008) In vivo responses to vaccination with Mage-b, GM-CSF and thioglycollate in a highly metastatic mouse breast tumor model, 4T1. Cancer Immunol Immunother 57: 1067-1077
16. Gravekamp C, Sypniewska R, Gauntt S, Tarango M, Price P, Reddick R (2004) Behavior of metastastic and non-metastatic breast tumors in old mice. EBM 229: 665-675
17. Gunn GR, Zubair A, Peters C, Pan ZK, Wu TC, Paterson Y (2001) Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T-cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. J Immunol 167: 6471-6479
18. Hayakawa Y, Takeda K, Yagita H, Smyth MJ, Van Kaer L, Okumura K, Saiki I (2002) IFNγ-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, α-galactosylceramide. Immunobiology 100: 1728-1733
19. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM (1993) Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547-549
20. Kruit WH, van Ojik HH, Brichard VG, Escudier B, Dorval T, Dréno B, Patel P, van Baren N, Avril MF, Piperno S, Khammari A, Stas M, Ritter G, Lethé B, Godelaine D, Brasseur F, Zhang Y, van der Bruggen P, Boon T, Eggermont AM, Marchand M (2005) Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma. Int J Cancer 117: 596-604
21. Kuang Y, Zhang Z, Zhang X (1998) Interleukin-6 and its soluble receptors in human breast cancer. Zhonghua Zhong Liu Za Zhi 20: 305-357
22. Kurtz JE, Dufour P (2002) Strategies for improving quality of life in older patients with metastatic breast cancer. Drugs Aging 19: 605-622
23. Lelekakis M, Moseley JM, Martin TJ, Hards D, Williams E, Ho P, Lowen D, Javni J, Miller FR, Slavin J, Anderson RL (1999) A novel orthotopic model of breast cancer metastasis to bone. Clin Exp Metastasis 17: 163-170
24. Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrman V, Doherty G, Drebin JA, Strasberg SM, Eberlein TJ, Goedegebuure PS, Linehan DC (2002) Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment in patients with pancreas or breast adenocarcinoma. J Immunol 169: 2756-2761
25. Lurquin C, Lethe B, De Plaen E, Corbiere PG, Boon T (2005) Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen. JEM 201: 249-257
26. Marchand M, Punt CJ, Aamdal S, Escudier B, Kruit WH, Keilholz U, Håkansson L, van Baren N, Humblet Y, Mulders P, Avril MF, Eggermont AM, Scheibenbogen C, Uiters J, Wanders J, Delire M, Boon T, Stoter G (2003) Immunization of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report. Eur J Cancer 39: 70-77
27. Messingham KAN, Badovinac VP, Jabbari A, Harty JT (2007) A role for IFNγ antigen-specific CD8+ T cells in protective immunity to Listeria monocytogenes. J Immunol 179: 2457-2466
28. Pardal R, Clarke MF, Morrison SJ (2003) Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3: 895-902
29. Pan ZK, Weiskirch LM, Paterson Y (1999) Regression of established B16F10 melanoma with recombinant Listeria monocytogenes vaccine. Cancer Res 59: 5264-5269
30. Park JW, Kwon TK, Kim IH, Sohn SS, Kim YS, Kim CI, Bae OS, Lee KS, Lee KD, Lee CS, Chang HK, Choe BK, Ahn SY, Jeon CH (2002) A new strategy for the diagnosis of MAGE-expressing cancers. J Immunol 79: 79-86
31. Park SJ, Nakgawa T, Kitamura H, Atsumi T, Kamon H, Sawa S, Kamimura D, Ueda N, Iwakura Y, Ishihara K, Murakami M, Hirano T (2004) IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J Immunol 173: 3844-3854
32. Paterson Y, Maciag PC (2005) Listeria-based vaccines for cancer treatment. Curr Opin Mol Ther 7: 454-460
33. Plitas G, Chaudry UI, Kingham TP, Raab JR, DeMatteo RP (2007) NK dendritic cells are innate immune responders to Listeria monocytogenes infection. J Immunol 178: 4411-4416
34. Qian F, Gnjatic S, Jager E, Santiago D, Jungbluth A, Grande C, Schneider S, Keitz B, Driscoll D, Ritter G, Lele S, Sood A, Old LJ, Odunsi K (2004) Th1/Th2 CD4+ T cell responses against NY-ESO-1 in HLA-DPB1*0401/0402 patients with epithelial ovarian cancer. Cancer Immun 4: 12-20
35. Rak JW, McEachern D, Miller FR (1992) Sequential alteration of peanut agglutinin binding-glycoprotein expression during progression in murine mammary neoplasia. Br J Cancer 65: 641-648
36. Reeves FR, Reeves PA (2003) Current protocols in immunology. In Care and Handling of Laboratory Animals, Coligan JE, Kruisbeek AM, Bierer BE, Margulies DH, Shevach EM, Strober W (eds), Vol. 1, City of University of New York Medical School, John and Wiley and Sons Inc, Food and Drug Administration: Bethesda, Maryland. P1.9.1-1.9.3
37. Rothman J (2008) The First Use of a Live Listeria Cancer Vaccine in Man. AACR Conference: San Diego, CA. 12-16 April 2008. Abstract 225
38. Scart H, Cantin J, Levin M (2002) Clinical practice guidelines for the care and treatment of breast cancer: Mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer (summary of the 2002 update). CMAJ 167: 145-155
39. Singh R, Domineicki ME, Jaffee EM, Paterson Y (2005) Fusion of Listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse. J Immunol 175: 3663-3673
40. Sotiriou C, Lacroix M, Lespagnard L, Larsimont D, Paesmans M, Body JJ (2001) Interleukins-6 and -11 expression in primary breast cancer and subsequent development of bone metastases. Cancer Lett 169: 87-95
41. Sypniewska RK, Hoflack L, Tarango M, Gauntt S, Leal BZ, Reddick RL, Gravekamp C (2005) Prevention of metastases with a Mage-b DNA vaccine in a mouse breast tumor model: potential for breast cancer therapy. BCRT 91: 19-28
42. Thurner B, Haendle I, Roder C, Dieckmann D, Keikavoussi P, Jonuleit H, Bender A, Maczek C, Schreiner D, von den Driesch P, Bröcker EB, Steinman RM, Enk A, Kämpgen E, Schuler G (1999) Vaccination with Mage-3A1 peptide-pulsed mature monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced Stage IV melanoma. JEM 190: 1669-1678
43. Van Baren N, Bonnet MC, Dreno B, Khammari A, Dorval T, Piperno-Neumann S, Liénard D, Speiser D, Marchand M, Brichard VG, Escudier B, Négrier S, Dietrich PY, Maraninchi D, Osanto S, Meyer RG, Ritter G, Moingeon P, Tartaglia J, van der Bruggen P, Coulie PG, Boon T (2005) Tumoral and immunological response after vaccination of melanoma patients with ALVAC virus encoding MAGE antigens recognized by T cells. J Clin Oncol 23: 9008-9021
44. Vazquez-Boland JA, Kuhn M, Berche P, Chakraborty T, Dominguez-Bernal G, Goebel W, Gonzalez-Zorn B, Wehland J, Kreft J (2001) Listeria Pathogenesis and molecular virulence determinants. Clin Microbiol Rev 14: 584-640
45. Xie J, Qian J, Wang S, Freeman III ME, Epstein J, Yi Q (2003) Novel and detrimental effects of lipopolysccharide on in vitro generation of immature dendritic cells: Involvement of mitogen-activated protein kinase p38. J Immunol 171: 4792-4800
46. Yang B, O'Herrin SM, Wu J, Reagan-Shaw S, Ma Y, Bhat KM, Gravekamp C, Setaluri V, Peters N, Hoffmann FM, Peng H, Ivanov AV, Simpson AJ, Longley BJ (2007) MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines. Cancer Res 67: 9954-9962